Agilent Technologies EBIT 2010-2025 | A
Agilent Technologies annual and quarterly EBIT history from 2010 to 2025. EBIT can be defined as earnings before interest and taxes.
- Agilent Technologies EBIT for the quarter ending April 30, 2025 was $300M, a 17.36% decline year-over-year.
- Agilent Technologies EBIT for the twelve months ending April 30, 2025 was $1.417B, a 10.02% increase year-over-year.
- Agilent Technologies 2024 annual EBIT was $1.488B, a 10.22% increase from 2023.
- Agilent Technologies 2023 annual EBIT was $1.35B, a 16.56% decline from 2022.
- Agilent Technologies 2022 annual EBIT was $1.618B, a 20.12% increase from 2021.
| Agilent Technologies Annual EBIT (Millions of US $) |
|
|---|---|
| 2024 | $1,488 |
| 2023 | $1,350 |
| 2022 | $1,618 |
| 2021 | $1,347 |
| 2020 | $846 |
| 2019 | $941 |
| 2018 | $904 |
| 2017 | $807 |
| 2016 | $615 |
| 2015 | $522 |
| 2014 | $419 |
| 2013 | $386 |
| 2012 | $1,119 |
| 2011 | $1,071 |
| 2010 | $566 |
| 2009 | $47 |
| Agilent Technologies Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2025-04-30 | $300 |
| 2025-01-31 | $376 |
| 2024-10-31 | $408 |
| 2024-07-31 | $333 |
| 2024-04-30 | $363 |
| 2024-01-31 | $384 |
| 2023-10-31 | $408 |
| 2023-07-31 | $133 |
| 2023-04-30 | $383 |
| 2023-01-31 | $426 |
| 2022-10-31 | $471 |
| 2022-07-31 | $411 |
| 2022-04-30 | $360 |
| 2022-01-31 | $376 |
| 2021-10-31 | $395 |
| 2021-07-31 | $336 |
| 2021-04-30 | $288 |
| 2021-01-31 | $328 |
| 2020-10-31 | $299 |
| 2020-07-31 | $230 |
| 2020-04-30 | $102 |
| 2020-01-31 | $215 |
| 2019-10-31 | $250 |
| 2019-07-31 | $225 |
| 2019-04-30 | $216 |
| 2019-01-31 | $250 |
| 2018-10-31 | $244 |
| 2018-07-31 | $221 |
| 2018-04-30 | $210 |
| 2018-01-31 | $229 |
| 2017-10-31 | $199 |
| 2017-07-31 | $201 |
| 2017-04-30 | $201 |
| 2017-01-31 | $206 |
| 2016-10-31 | $183 |
| 2016-07-31 | $146 |
| 2016-04-30 | $131 |
| 2016-01-31 | $155 |
| 2015-10-31 | $156 |
| 2015-07-31 | $144 |
| 2015-04-30 | $107 |
| 2015-01-31 | $115 |
| 2014-10-31 | $174 |
| 2014-07-31 | $131 |
| 2014-04-30 | $94 |
| 2014-01-31 | $124 |
| 2013-10-31 | $285 |
| 2013-07-31 | $236 |
| 2013-04-30 | $213 |
| 2013-01-31 | $217 |
| 2012-10-31 | $278 |
| 2012-07-31 | $270 |
| 2012-04-30 | $300 |
| 2012-01-31 | $271 |
| 2011-10-31 | $313 |
| 2011-07-31 | $281 |
| 2011-04-30 | $266 |
| 2011-01-31 | $211 |
| 2010-10-31 | $203 |
| 2010-07-31 | $115 |
| 2010-04-30 | $154 |
| 2010-01-31 | $94 |
| 2009-10-31 | $71 |
| 2009-07-31 | $-1 |
| 2009-04-30 | $-47 |
| 2009-01-31 | $24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.815B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.372B | 27.70 |
| Boston Scientific (BSX) | United States | $149.971B | 37.54 |
| Stryker (SYK) | United States | $142.469B | 29.79 |
| EssilorLuxottica (ESLOY) | France | $128.310B | 0.00 |
| Medtronic (MDT) | Ireland | $109.952B | 15.59 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.265B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.015B | 26.80 |
| ResMed (RMD) | United States | $36.786B | 27.63 |
| GE HealthCare Technologies (GEHC) | United States | $32.917B | 15.63 |
| Terumo (TRUMY) | Japan | $26.606B | 34.56 |
| Koninklijke Philips (PHG) | Netherlands | $21.242B | 14.90 |
| Insulet (PODD) | United States | $21.238B | 83.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.915B | 11.51 |
| Baxter (BAX) | United States | $15.293B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.517B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.313B | 21.97 |
| Lantheus Holdings (LNTH) | United States | $5.465B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.133B | 18.46 |
| Perrigo (PRGO) | Ireland | $3.618B | 9.17 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.366B | 15.33 |
| ICU Medical (ICUI) | United States | $3.165B | 23.34 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.916B | 13.18 |
| LeMaitre Vascular (LMAT) | United States | $1.846B | 41.26 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.335B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.144B | 11.62 |
| Neogen (NEOG) | United States | $1.083B | 13.86 |
| Green Thumb Industries (GTBIF) | United States | $1.059B | 23.81 |
| BioLife Solutions (BLFS) | United States | $1.022B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.971B | 12.41 |
| InMode (INMD) | Israel | $0.843B | 8.50 |
| Kestra Medical Technologies (KMTS) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.643B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.545B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.512B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.282B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.263B | 78.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.93 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Quanterix (QTRX) | United States | $0.248B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.240B | 10.90 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.236B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.15 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.76 |
| Jin Medical (ZJYL) | China | $0.110B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.25 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |